Selected article for: "cell surface and IFN receptor"

Author: Lippens, Carla; Duraes, Fernanda V.; Dubrot, Juan; Brighouse, Dale; Lacroix, Mathilde; Irla, Magali; Aubry-Lachainaye, Jean-Pierre; Reith, Walter; Mandl, Judith N.; Hugues, Stéphanie
Title: IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity
  • Document date: 2016_12_23
  • ID: sl8148ap_3
    Snippet: Indoleamine 2,3-dioxygenase (IDO) is an immunomodulatory enzyme involved in the initial and the rate-limiting step of tryptophan catabolism. Upon inflammation, IDO production has been shown to compromise T cell proliferation, promote T cell anergy and Tregs [24], [25], [26]. Depending on the experimental context, IDO can be induced either by IFN-γ, IFN-α/β, or TGF-β. CTLA-4 binding to cell-surface expressed costimulatory molecules promotes ID.....
    Document: Indoleamine 2,3-dioxygenase (IDO) is an immunomodulatory enzyme involved in the initial and the rate-limiting step of tryptophan catabolism. Upon inflammation, IDO production has been shown to compromise T cell proliferation, promote T cell anergy and Tregs [24], [25], [26]. Depending on the experimental context, IDO can be induced either by IFN-γ, IFN-α/β, or TGF-β. CTLA-4 binding to cell-surface expressed costimulatory molecules promotes IDO production by pDCs through IFN-γ or IFN-α/β signalling [27], [28], [29], [30]. Furthermore CD200-Ig binding to his cognate receptor induces IDO in an IFN-α/β dependent signalling pathway [31]. Both IFN-γ and IFN-α/β pathways result in IDO+ immunosuppressive effects which are closely dependent on the catalytic activity of the enzyme.

    Search related documents:
    Co phrase search for related documents
    • catalytic activity and cell proliferation: 1, 2
    • catalytic activity and cell surface: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • catalytic activity and enzyme catalytic activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • cell anergy and enzyme catalytic activity: 1
    • cell proliferation and cognate receptor: 1, 2
    • cell proliferation and costimulatory molecule: 1, 2, 3
    • cell proliferation and dependent signalling pathway: 1
    • cell proliferation and β α IFN pathway: 1
    • cell proliferation and immunosuppressive effect: 1, 2
    • cell surface and cognate receptor: 1, 2, 3, 4, 5, 6, 7, 8
    • cell surface and cognate receptor bind: 1
    • cell surface and costimulatory molecule: 1
    • cell surface and α IFN β signal: 1
    • cell surface and IDO induce: 1
    • cell surface bind and cognate receptor: 1
    • cell surface bind and cognate receptor bind: 1
    • α IFN β signal and β α IFN pathway: 1, 2
    • β α IFN pathway and IDO induce: 1